Biomaterials Market by Type of Materials (Metallic, Ceramic, Polymers, Natural), Application (Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Neurological disorders, Tissue Engineering, Ophthalmology) - Global Forecast to 2025
Updated on : April 13, 2023
The global biomaterials market in terms of revenue was estimated to be worth $35.5 billion in 2020 and is poised to reach $47.5 billion by 2025, growing at a CAGR of 6.0% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. Market growth is driven mainly by factors such as the increased funds & grants by government bodies worldwide for the development of novel biomaterials, rising demand for medical implants, and the rising incidence of cardiovascular diseases, increasing research on regenerative medicine.
To know about the assumptions considered for the study, Request for Free Sample Report
Biomaterials Market Dynamics
Driver: Growing demand for biomaterials in plastic surgery and wound healing applications
Plastic surgery and wound healing are prominent application areas for biomaterial-based products. In plastic surgery, biomaterials are widely used for implanting, rebuilding, repairing, and covering soft-tissue wounds, burns, or gaping holes in the human body naturally and safely. Innovations and technological advancements, coupled with the growing acceptance of aesthetic cosmetic procedures, would drive the demand for biomaterials in plastic surgery and wound healing applications in the coming years
Restraint: Stringent clinical & regulatory processes
Biomaterial-based medical devices are stringently regulated in several regions, including North America, Europe, and Asia, to ensure their quality and efficacy. This is primarily because most biomaterial-based medical devices are implantable. All new biomaterials require proof that they are safe and effective before they can be approved for marketing. In the US, the process for approval follows strict guidelines and regulations set by the FDA. According to the FDA, biomaterial-based products, such as implantable pacemakers, stents, and heart valves, are classified as Class III devices, which pose the highest potential risk of illness or injury. Thus, these devices are subjected to the premarket approval application pathway (the most stringent type of device marketing application).
Opportunity: Growing healthcare markets in emerging economies
The biomaterials market in emerging countries is expected to witness significant growth during the forecast period. This can majorly be attributed to the increasing patient population, rising adoption of implantable devices, growing awareness of CVDs, rising disposable income, improving healthcare infrastructure, and the presence of less-stringent regulatory guidelines (as compared to developed countries) in these countries.
Brazil, Russia, India, China, and South Africa (BRICS) are among the fastest-growing economies in the world. The World Economic Forum has estimated these emerging economies would account for one-third of the global healthcare expenditure by 2020. The growing demand for surgical procedures, rising geriatric population, and the increasing incidence of target diseases are some of the major factors that are expected to drive the demand for advanced healthcare services and novel medical devices in the respective healthcare systems of these countries. This is expected to offer potential growth opportunities to players operating in the biomaterials market in the coming years.
By type of material, the metallic biomaterials segment accounted for the largest share of the biomaterials market.
Based on type of material, the market is segmented into Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials, and Natural Biomaterials. Metallic Biomaterials dominated the market. The dominant share of this segment can primarily be attributed to the wide use of metals in the manufacturing of medical devices used in cardiovascular, dental, and orthopedic applications. The polymeric biomaterials segment, on the other hand, is expected to grow at the highest CAGR during the forecast period, mainly due to the increasing use of polymers in soft-tissue applications such as plastic surgeries.
By application, the cardiovascular segment accounted for the largest share of the biomaterials market.
Based on application, the market is categorized into Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Tissue Engineering, Ophthalmology, Neurological/CNS, and Other Applications. The cardiovascular application segment dominated the market. The large share of the cardiovascular segment can be attributed to the increasing prevalence of cardiovascular diseases, rising geriatric population, increasing angiography procedures, and the growing adoption of cardiac stents, pacemakers, and implantable cardiac defibrillators.
North America accounted for the largest share of the biomaterials market.
North America accounted for the largest share of this market, followed by Europe. The large share of the North American regional segment can be attributed to the increase in biomaterial-based research, rising demand for plastic surgeries, growing incidence of cancer, and the rising prevalence of cardiovascular diseases.
Key players in biomaterials market include BASF SE (Germany), Covestro AG (Germany), Celanese Corporation (US), Corbion (Netherlands), Royal DSM (Netherlands), Evonik Industries (Germany), Carpenter Technology Corporation (US), Berkeley Advanced Biomaterials (US), Cam Bioceramics B.V. (Netherlands), CoorsTek Inc. (US), CeramTec (Germany), and Gelita AG (Germany).
Biomaterials Market Scope
Report Metrics |
Details |
Market Revenue in 2020 |
$35.5 billion |
Projected Revenue by 2025 |
$47.5 billion |
Revenue Rate |
Poised to grow at a CAGR of 6.0% |
Market Driver |
Growing demand for biomaterials in plastic surgery and wound healing applications |
Market Opportunity |
Growing healthcare markets in emerging economies |
This research report categorizes the global biomaterials market to forecast revenue and analyze trends in each of the following submarkets
By Type
-
Metallic Biomaterials
- Stainless Steel
- Titanium & Titanium Alloys
- Cobalt-Chrome Alloys
- Gold
- Silver
- Magnesium
-
Polymeric Biomaterials
- Polymethylmethacrylate
- Polyethylene
- Polyester
- Silicone Rubber
- Nylon
- Polyetheretherketone
- Other Polymeric Biomaterials
-
Ceramics
- Calcium Phosphate
- Zirconia
- Aluminum Oxide
- Calcium Sulfate
- Carbon
- Glass
-
Natural Biomaterials
- Hyaluronic Acid
- Collagen
- Gelatin
- Fibrin
- Cellulose
- Chitin
- Alginates
- Silk
By Application
-
Cardiovascular
- Catheters
- Stents
- Implantable Cardiac Defibrillators
- Pacemakers
- Sensors
- Heart Valves
- Vascular Grafts
- Guidewires
- Others
-
Orthopedic
-
Joint Replacement
- Knee Replacement
- Hip Replacement
- Shoulder Replacement
- Others
- Viscosupplementation
-
Bioresorbable Tissue Fixation
- Suture Anchors
- Interference Screws
- Meniscal Repair Tacks
- Meshes
-
Spine
- Spinal Fusion Surgeries
- Minimally Invasive Fusion Surgeries
-
Motion Preservation & Dynamic Stabilization Surgeries
- Pedicle-Based Rod Systems
- Interspinous Spacers
- Artificial Discs
-
Fracture Fixation Devices
- Bone Plates
- Screws
- Pins
- Rods
- Wires
- Synthetics Bone Grafts
-
Joint Replacement
-
Ophthalmology
-
Contact Lenses
- Intraocular Lenses
- Functional Replacement of Ocular Tissues
- Synthetic Corneas
- Others
-
Contact Lenses
-
Dental
- Dental Implants
- Dental Bone Grafts & Substitutes
- Dental Membranes
- Tissue Regeneration
-
Plastic Surgery
- Soft-Tissue Fillers
- Craniofacial Surgery
-
Wound Healing
-
Wound Closure Devices
- Sutures
- Staples
- Surgical Hemostats
- Internal Tissue Sealants
- Adhesion Barriers
- Hernia Meshes
-
Wound Closure Devices
-
Tissue Engineering
- Scaffolds for Regenerative Medicine
- Biosensing
- Tailoring of Inorganic Nanoparticles
-
Neurological/Central Nervous System Applications
- Shunting Systems
- Cortical Neural Prosthetics
- Hydrogel Scaffolds for CNS Repair
- Neural Stem Cell Encapsulation
-
Other Applications
- Drug Delivery Systems
- Gastrointestinal Applications
- Bariatric Surgery
- Urinary Applications
By Region
-
North America
- US
- Canada
-
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe (RoE)
-
Asia Pacific (APAC)
- Japan
- China
- India
- Rest of Asia Pacific (RoAPAC)
- Rest of the World (RoW)
Recent Developments
- In 2019, Royal DSM (Netherlands) and ProMed Pharma (US) partnered for the development of novel sustained release drug delivery solutions in the polymeric drug delivery area.
- In 2018, Covestro AG (Germany) signed an MoU with a group of ten companies and two research organizations with an aim to build a Composite Application Center (CAC) in Singapore. This was aimed to develop end-to-end solutions for advanced composites, such as thermoplastic materials.
- In 2019, Celanese Corporation (US) announced an expansion of its production facility of thermoplastic co-polyesters. This expansion is expected to support the demand of its global engineered
Frequently Asked Questions (FAQ):
What is the projected market revenue value of the global biomaterials market?
The global biomaterials market boasts a total revenue value of $47.5 billion by 2025.
What is the estimated growth rate (CAGR) of the global biomaterials market?
The global market for biomaterials has an estimated compound annual growth rate (CAGR) of 6.0% and a revenue size in the region of $35.5 billion in 2020.
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 31)
1.1 OBJECTIVES OF STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
FIGURE 1 GLOBAL BIOMATERIALS MARKET SEGMENTATION
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 35)
2.1 RESEARCH DATA
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 3 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS
2.2 MARKET SIZE ESTIMATION
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 6 MARKET SIZE ESTIMATION: GLOBAL MARKET
FIGURE 7 SEGMENTAL ASSESSMENT: MARKET
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 8 DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ESTIMATION
2.5 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY (Page No. - 44)
FIGURE 9 BIOMATERIALS MARKET, BY TYPE, 2020 VS. 2025
FIGURE 10 METALLIC BIOMATERIALS MARKET, BY TYPE, 2020 VS. 2025
FIGURE 11 CERAMIC BIOMATERIALS MARKET, BY TYPE, 2020 VS. 2025
FIGURE 12 POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2020 VS. 2025
FIGURE 13 NATURAL BIOMATERIALS MARKET, BY TYPE, 2020 VS. 2025
FIGURE 14 CARDIOVASCULAR APPLICATIONS DOMINATED THE GLOBAL MARKET IN 2019
FIGURE 15 GEOGRAPHICAL SNAPSHOT OF THE GLOBAL MARKET
4 PREMIUM INSIGHTS (Page No. - 50)
4.1 BIOMATERIALS MARKET OVERVIEW
FIGURE 16 INCREASING DEMAND FOR IMPLANTABLE DEVICES TO DRIVE THE GROWTH OF THE MARKET
4.2 NORTH AMERICA: MARKET, BY TYPE & COUNTRY (2019)
FIGURE 17 METALLIC BIOMATERIALS TO DOMINATE THE NORTH AMERICAN MARKET IN 2019
4.3 METALLIC BIOMATERIALS MARKET, BY TYPE
FIGURE 18 TITANIUM & TITANIUM ALLOYS ARE PROJECTED TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
5 MARKET OVERVIEW (Page No. - 53)
5.1 INTRODUCTION
5.2 BIOMATERIALS MARKET DYNAMICS
FIGURE 19 GLOBAL MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, CHALLENGES, AND TRENDS
5.2.1 DRIVERS
5.2.1.1 Increased funds and grants by government bodies and universities for the development of novel biomaterials
5.2.1.2 Increasing demand for implantable devices
5.2.1.3 Growing demand for biomaterials in plastic surgery and wound healing applications
5.2.1.4 Rising incidence of cardiovascular diseases
5.2.1.5 Increasing research on regenerative medicine
5.2.2 RESTRAINTS
5.2.2.1 Stringent clinical & regulatory processes
5.2.2.2 Unfavorable healthcare reforms in the US
5.2.3 OPPORTUNITIES
5.2.3.1 Growing healthcare market in emerging economies
5.2.3.2 Increasing number of free-trade agreements
5.2.4 CHALLENGES
5.2.4.1 Limitations of biomaterial-based products
5.2.4.2 Shortage of skilled surgeons
5.2.5 TRENDS
5.2.5.1 Impact of COVID-19 on the global market
6 REGULATORY ASSESSMENT (Page No. - 61)
6.1 INTRODUCTION
6.2 US
6.2.1 INTRODUCTION
6.2.2 FDA DEVICE CLASSIFICATION
FIGURE 20 US: REGULATORY APPROVAL PROCESS
6.2.3 US: REGULATORY APPROVAL TIMELINE ASSESSMENT
FIGURE 21 REGULATORY APPROVAL TIMELINE IN THE US
6.2.4 STRINGENT FDA REGULATIONS GOVERNING PRODUCT APPROVALS
6.3 CANADA
6.3.1 INTRODUCTION
FIGURE 22 CANADA: REGULATORY APPROVAL PROCESS
6.3.2 CANADA: REGULATORY APPROVAL TIMELINE ASSESSMENT
FIGURE 23 REGULATORY APPROVAL TIMELINE IN CANADA
6.3.3 HEALTH CANADA CLASSIFICATION
6.4 EUROPE
6.4.1 INTRODUCTION
6.4.2 EUROPEAN MEDICAL DEVICE CLASSIFICATION
FIGURE 24 EUROPE: REGULATORY APPROVAL PROCESS
6.4.3 EUROPE: REGULATORY APPROVAL TIMELINE ASSESSMENT
FIGURE 25 REGULATORY APPROVAL TIMELINE IN EUROPE
6.4.4 EUROPEAN REGULATORY PROCESS TO GET MORE STRINGENT IN FUTURE
6.5 JAPAN
6.5.1 INTRODUCTION
6.5.2 PMDA DEVICE CLASSIFICATION
FIGURE 26 JAPAN: REGULATORY APPROVAL PROCESS
6.5.3 JAPAN: REGULATORY APPROVAL TIMELINE ASSESSMENT
FIGURE 27 REGULATORY APPROVAL TIMELINE IN JAPAN
6.5.4 REVISION OF THE PHARMACEUTICAL AFFAIRS LAW (PAL) AND IMPLEMENTATION OF THE NEW PMD ACT IN JAPAN
6.6 CHINA
6.6.1 INTRODUCTION
6.6.2 CFDA DEVICE CLASSIFICATION
FIGURE 28 CHINA: REGULATORY APPROVAL PROCESS
6.6.3 CHINA: REGULATORY APPROVAL TIMELINE ASSESSMENT
FIGURE 29 REGULATORY APPROVAL TIMELINE IN CHINA
6.6.4 RISING HURDLES IN THE REGULATORY PROCESS IN CHINA
6.7 INDIA
6.7.1 INTRODUCTION
FIGURE 30 INDIA: REGULATORY APPROVAL PROCESS
6.7.2 INDIAN MEDICAL DEVICES CLASSIFICATION
6.8 AUSTRALIA
6.8.1 INTRODUCTION
6.8.2 TGA DEVICE CLASSIFICATION
FIGURE 31 AUSTRALIA: REGULATORY APPROVAL PROCESS
6.8.3 AUSTRALIA: REGULATORY APPROVAL TIMELINE ASSESSMENT
FIGURE 32 REGULATORY APPROVAL TIMELINE IN AUSTRALIA
7 BIOMATERIALS MARKET, BY TYPE (Page No. - 82)
7.1 INTRODUCTION
TABLE 1 IMPORTANT PROPERTIES OF BIOMATERIALS, BY APPLICATION
TABLE 2 GLOBAL MARKET, BY TYPE, 2016–2019
TABLE 3 GLOBAL MARKET, BY TYPE, 2020–2025
7.2 METALLIC BIOMATERIALS
TABLE 4 METALLIC MARKET, BY TYPE, 2016–2019
TABLE 5 METALLIC MARKET, BY TYPE, 2020–2025
TABLE 6 METALLIC MARKET, BY REGION, 2016–2019
TABLE 7 METALLIC MARKET, BY REGION, 2020–2025
7.2.1 STAINLESS STEEL
7.2.1.1 Stainless steel dominates the metallic biomaterials market
TABLE 8 STAINLESS STEEL MARKET, BY REGION, 2016–2019
TABLE 9 STAINLESS STEEL MARKET, BY REGION, 2020–2025
7.2.2 TITANIUM & TITANIUM ALLOYS
7.2.2.1 Growing number of joint replacement procedures will drive the market for titanium biomaterials
TABLE 10 TITANIUM & TITANIUM ALLOY MARKET, BY REGION, 2016–2019
TABLE 11 TITANIUM & TITANIUM ALLOY MARKET, BY REGION, 2020–2025
7.2.3 COBALT-CHROME ALLOYS
7.2.3.1 Low cost and excellent corrosion resistance have driven the use of cobalt-chrome alloys
TABLE 12 COBALT-CHROME ALLOY MARKET, BY REGION, 2016–2019
TABLE 13 COBALT-CHROME ALLOY MARKET, BY REGION, 2020–2025
7.2.4 GOLD
7.2.4.1 Expanding applications of gold nanoparticles to drive the demand for gold biomaterials
TABLE 14 GOLD MARKET, BY REGION, 2016–2019
TABLE 15 GOLD MARKET, BY REGION, 2020–2025
7.2.5 SILVER
7.2.5.1 Toxic properties and low aesthetic appeal likely to limit the use of silver in biomaterial-based products
TABLE 16 SILVER BIOMATERIALS MARKET, BY REGION, 2016–2019
TABLE 17 SILVER MARKET, BY REGION, 2020–2025
7.2.6 MAGNESIUM
7.2.6.1 Biodegradable characteristic of magnesium stimulates the growth of this market segment
TABLE 18 MAGNESIUM MARKET, BY REGION, 2016–2019
TABLE 19 MAGNESIUM MARKET, BY REGION, 2020–2025
7.3 POLYMERIC BIOMATERIALS
TABLE 20 APPLICATIONS OF SYNTHETIC POLYMERS
TABLE 21 POLYMERIC MARKET, BY TYPE, 2016–2019
TABLE 22 POLYMERIC MARKET, BY TYPE, 2020–2025
TABLE 23 POLYMERIC MARKET, BY REGION, 2016–2019
TABLE 24 POLYMERIC MARKET, BY REGION, 2020–2025
7.3.1 POLYMETHYLMETHACRYLATE (PMMA)
7.3.1.1 PMMA dominates the polymeric biomaterials market
TABLE 25 POLYMETHYLMETHACRYLATE MARKET, BY REGION, 2016–2019
TABLE 26 POLYMETHYLMETHACRYLATE MARKET, BY REGION, 2020–2025
7.3.2 POLYETHYLENE
7.3.2.1 Wear and tear resistance of polyethylene has made it popular in hip and knee joint replacements
TABLE 27 POLYETHYLENE MARKET, BY REGION, 2016–2019
TABLE 28 POLYETHYLENE MARKET, BY REGION, 2020–2025
7.3.3 POLYESTER
7.3.3.1 Biodegradable nature and biocompatibility of polyester will drive its use in various medical applications
TABLE 29 POLYESTER MARKET, BY REGION, 2016–2019
TABLE 30 POLYESTER MARKET, BY REGION, 2020–2025
7.3.4 POLYVINYLCHLORIDE
7.3.4.1 Heavy chlorine content of PVC is likely to hamper the market growth
TABLE 31 POLYVINYLCHLORIDE MARKET, BY REGION, 2016–2019
TABLE 32 POLYVINYLCHLORIDE MARKET, BY REGION, 2020–2025
7.3.5 SILICONE RUBBER
7.3.5.1 Silicone rubbers are non-reactive, stable, and resistant to extreme environments and temperatures
TABLE 33 SILICONE RUBBER MARKET, BY REGION, 2016–2019
TABLE 34 SILICONE RUBBER MARKET, BY REGION, 2020–2025
7.3.6 NYLON
7.3.6.1 Low weight, corrosion resistance, and wide applications of nylon are expected to drive the market demand
TABLE 35 NYLON BIOMATERIALS MARKET, BY REGION, 2016–2019
TABLE 36 NYLON MARKET, BY REGION, 2020–2025
7.3.7 POLYETHERETHERKETONE
7.3.7.1 PEEK is gaining popularity as a viable alternative to metals
TABLE 37 POLYETHERETHERKETONE MARKET, BY REGION, 2016–2019
TABLE 38 POLYETHERETHERKETONE MARKET, BY REGION, 2020–2025
7.3.8 OTHER POLYMERIC BIOMATERIALS
TABLE 39 OTHER POLYMERIC MARKET, BY REGION, 2016–2019
TABLE 40 OTHER POLYMERIC MARKET, BY REGION, 2020–2025
7.4 CERAMIC BIOMATERIALS
TABLE 41 CERAMIC MARKET, BY TYPE, 2016–2019
TABLE 42 CERAMIC MARKET, BY TYPE, 2020–2025
TABLE 43 CERAMIC MARKET, BY REGION, 2016–2019
TABLE 44 CERAMIC MARKET, BY REGION, 2020–2025
7.4.1 CALCIUM PHOSPHATE
7.4.1.1 Calcium phosphate is the largest segment in the ceramic biomaterials market
TABLE 45 CALCIUM PHOSPHATE MARKET, BY REGION, 2016–2019
TABLE 46 CALCIUM PHOSPHATE MARKET, BY REGION, 2020–2025
7.4.2 ZIRCONIA
7.4.2.1 Bio-inertness and low wear rate of zirconia will boost the market growth
TABLE 47 ZIRCONIA MARKET, BY REGION, 2016–2019
TABLE 48 ZIRCONIA MARKET, BY REGION, 2020–2025
7.4.3 ALUMINUM OXIDE
7.4.3.1 Increasing use of aluminum oxide in hip replacements and dental implants to drive the market
TABLE 49 ALUMINUM OXIDE MARKET, BY REGION, 2016–2019
TABLE 50 ALUMINUM OXIDE MARKET, BY REGION, 2020–2025
7.4.4 CALCIUM SULFATE
7.4.4.1 Fast resorption rate of calcium sulfate is likely to hamper its use
TABLE 51 CALCIUM SULFATE MARKET, BY REGION, 2016–2019
TABLE 52 CALCIUM SULFATE MARKET, BY REGION, 2020–2025
7.4.5 CARBON
7.4.5.1 Increasing use of carbon nanofibers in regenerative medicine and cancer treatment will drive market growth
TABLE 53 CARBON MARKET, BY REGION, 2016–2019
TABLE 54 CARBON MARKET, BY REGION, 2020–2025
7.4.6 GLASS
7.4.6.1 Rising number of orthopedic and dental procedures is likely to drive the demand for glass biomaterials
TABLE 55 GLASS MARKET, BY REGION, 2016–2019
TABLE 56 GLASS MARKET, BY REGION, 2020–2025
7.5 NATURAL BIOMATERIALS
TABLE 57 APPLICATIONS OF NATURAL BIOMATERIALS
TABLE 58 NATURAL BIOMATERIALS MARKET, BY TYPE, 2016–2019
TABLE 59 NATURAL MARKET, BY TYPE, 2020–2025
TABLE 60 NATURAL MARKET, BY REGION, 2016–2019
TABLE 61 NATURAL MARKET, BY REGION, 2020–2025
7.5.1 HYALURONIC ACID
7.5.1.1 Rising prevalence of osteoarthritis to drive the hyaluronic acid market
TABLE 62 HYALURONIC ACID MARKET, BY REGION, 2016–2019
TABLE 63 HYALURONIC ACID MARKET, BY REGION, 2020–2025
7.5.2 COLLAGEN
7.5.2.1 Rising prevalence of target applications to drive growth in the collagen market
TABLE 64 COLLAGEN MARKET, BY REGION, 2016–2019
TABLE 65 COLLAGEN MARKET, BY REGION, 2020–2025
7.5.3 GELATIN
7.5.3.1 Low cost of gelatin to drive its market growth
TABLE 66 GELATIN MARKET, BY REGION, 2016–2019
TABLE 67 GELATIN MARKET, BY REGION, 2020–2025
7.5.4 FIBRIN
7.5.4.1 Fibrin biomaterials were among the first used to prevent bleeding
TABLE 68 FIBRIN MARKET, BY REGION, 2016–2019
TABLE 69 FIBRIN MARKET, BY REGION, 2020–2025
7.5.5 CELLULOSE
7.5.5.1 Cellulose finds applications in wound healing, skin regeneration, and ophthalmology
TABLE 70 CELLULOSE MARKET, BY REGION, 2016–2019
TABLE 71 CELLULOSE MARKET, BY REGION, 2020–2025
7.5.6 CHITIN
7.5.6.1 Chitin accelerates skin regeneration and possesses high biocompatibility
TABLE 72 CHITIN MARKET, BY REGION, 2016–2019
TABLE 73 CHITIN MARKET, BY REGION, 2020–2025
7.5.7 ALGINATES
7.5.7.1 Various applications of alginates include wound healing, tissue engineering & regenerative medicine, and drug delivery
TABLE 74 ALGINATE MARKET, BY REGION, 2016–2019
TABLE 75 ALGINATE MARKET, BY REGION, 2020–2025
7.5.8 SILK
7.5.8.1 Flexibility, glossiness, and adhesive abilities of silk have made it popular in cosmetic applications
TABLE 76 SILK MARKET, BY REGION, 2016–2019
TABLE 77 SILK MARKET, BY REGION, 2020–2025
8 BIOMATERIALS MARKET, BY APPLICATION (Page No. - 119)
8.1 INTRODUCTION
TABLE 78 GLOBAL MARKET, BY APPLICATION, 2016–2019
TABLE 79 MARKET, BY APPLICATION, 2020–2025
8.2 CARDIOVASCULAR
TABLE 80 MARKET FOR CARDIOVASCULAR APPLICATIONS, BY PRODUCT, 2016–2019
TABLE 81 MARKET FOR CARDIOVASCULAR APPLICATIONS, BY PRODUCT, 2020–2025
TABLE 82 MARKET FOR CARDIOVASCULAR APPLICATIONS, BY REGION, 2016–2019
TABLE 83 BIOMATERIALS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY REGION, 2020–2025
8.2.1 CATHETERS
8.2.1.1 Shift in patient preference from traditional open surgeries to minimally invasive surgeries to drive the catheters market
TABLE 84 MARKET FOR CATHETERS, BY REGION, 2016–2019
TABLE 85 MARKET FOR CATHETERS, BY REGION, 2020–2025
8.2.2 STENTS
8.2.2.1 Increasing number of coronary intervention procedures to boost the demand for implantable stents
TABLE 86 MARKET FOR STENTS, BY REGION, 2016–2019
TABLE 87 MARKET FOR STENTS, BY REGION, 2020–2025
8.2.3 IMPLANTABLE CARDIAC DEFIBRILLATORS
8.2.3.1 Growing geriatric population is expected to increase the demand for implantable cardiac defibrillators
TABLE 88 MARKET FOR IMPLANTABLE CARDIAC DEFIBRILLATORS, BY REGION, 2016–2019
TABLE 89 MARKET FOR IMPLANTABLE CARDIAC DEFIBRILLATORS, BY REGION, 2020–2025
8.2.4 PACEMAKERS
8.2.4.1 High prevalence of bradycardia is increasing the demand for pacemakers
TABLE 90 GLOBAL MARKET FOR PACEMAKERS, BY REGION, 2016–2019
TABLE 91 MARKET FOR PACEMAKERS, BY REGION, 2020–2025
8.2.5 SENSORS
8.2.5.1 Increasing prevalence of cardiac disorders is boosting the demand for cardiovascular sensors
TABLE 92 MARKET FOR SENSORS, BY REGION, 2016–2019
TABLE 93 MARKET FOR SENSORS, BY REGION, 2020–2025
8.2.6 HEART VALVES
8.2.6.1 Growing geriatric population is set to increase the demand for prosthetic valves
TABLE 94 BIOMATERIALS USED FOR DIFFERENT VALVE COMPONENTS
TABLE 95 MARKET FOR HEART VALVES, BY REGION, 2016–2019
TABLE 96 MARKET FOR HEART VALVES, BY REGION, 2020–2025
8.2.7 VASCULAR GRAFTS
8.2.7.1 Various research studies related to the use of biomaterials in vascular grafts will open opportunities for growth of the market
TABLE 97 GLOBAL MARKET FOR VASCULAR GRAFTS, BY REGION, 2016–2019
TABLE 98 MARKET FOR VASCULAR GRAFTS, BY REGION, 2020–2025
8.2.8 GUIDEWIRES
8.2.8.1 Guidewires are widely used for guiding catheters and placing stents inside the heart
TABLE 99 MARKET FOR GUIDEWIRES, BY REGION, 2016–2019
TABLE 100 MARKET FOR GUIDEWIRES, BY REGION, 2020–2025
8.2.9 OTHER PRODUCTS
TABLE 101 MARKET FOR OTHER PRODUCTS, BY REGION, 2016–2019
TABLE 102 MARKET FOR OTHER PRODUCTS, BY REGION, 2020–2025
8.3 ORTHOPEDIC
TABLE 103 BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2016–2019
TABLE 104 MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2020–2025
TABLE 105 MARKET FOR ORTHOPEDIC APPLICATIONS, BY REGION, 2016–2019
TABLE 106 MARKET FOR ORTHOPEDIC APPLICATIONS, BY REGION, 2020–2025
8.3.1 JOINT REPLACEMENT
TABLE 107 JOINT REPLACEMENT MARKET, BY TYPE, 2016–2019
TABLE 108 JOINT REPLACEMENT MARKET, BY TYPE, 2020–2025
TABLE 109 JOINT REPLACEMENT MARKET, BY REGION, 2016–2019
TABLE 110 JOINT REPLACEMENT MARKET, BY REGION, 2020–2025
8.3.1.1 Knee replacement
8.3.1.1.1 Increasing number of knee replacement procedures across the globe to drive market growth
TABLE 111 KNEE REPLACEMENT MARKET, BY REGION, 2016–2019
TABLE 112 KNEE REPLACEMENT MARKET, BY REGION, 2020–2025
8.3.1.2 Hip replacement
8.3.1.2.1 Hip and knee joint replacements are the most commonly performed procedures in the US—a key factor driving growth
TABLE 113 HIP REPLACEMENT MARKET, BY REGION, 2016–2019
TABLE 114 HIP REPLACEMENT MARKET, BY REGION, 2020–2025
8.3.1.3 Shoulder replacement
8.3.1.3.1 Shoulder replacement is the most common joint replacement surgery conducted globally
TABLE 115 SHOULDER REPLACEMENT BIOMATERIALS MARKET, BY REGION, 2016–2019
TABLE 116 SHOULDER REPLACEMENT MARKET, BY REGION, 2020–2025
8.3.1.4 Other joint replacement applications
TABLE 117 OTHER JOINT REPLACEMENT MARKET, BY REGION, 2016–2019
TABLE 118 OTHER JOINT REPLACEMENT MARKET, BY REGION, 2020–2025
8.3.2 VISCOSUPPLEMENTATION
8.3.2.1 Rising cases of osteoarthritis will drive growth in the viscosupplementation market
TABLE 119 VISCOSUPPLEMENTATION MARKET, BY REGION, 2016–2019
TABLE 120 VISCOSUPPLEMENTATION MARKET, BY REGION, 2020–2025
8.3.3 BIORESORBABLE TISSUE FIXATION
TABLE 121 BIORESORBABLE BIOMATERIALS MARKET, BY PRODUCT, 2016–2019
TABLE 122 BIORESORBABLE MARKET, BY PRODUCT, 2020–2025
TABLE 123 BIORESORBABLE MARKET, BY REGION, 2016–2019
TABLE 124 BIORESORBABLE MARKET, BY REGION, 2020–2025
8.3.3.1 Suture anchors
8.3.3.1.1 Growing awareness about suture anchor devices will drive market growth
TABLE 125 GLOBAL MARKET FOR SUTURE ANCHORS, BY REGION, 2016–2019
TABLE 126 MARKET FOR SUTURE ANCHORS, BY REGION, 2020–2025
8.3.3.2 Interference screws
8.3.3.2.1 Increasing awareness about ACL will contribute to market growth
TABLE 127 MARKET FOR INTERFERENCE SCREWS, BY REGION, 2016–2019
TABLE 128 MARKET FOR INTERFERENCE SCREWS, BY REGION, 2020–2025
8.3.3.3 Meniscal repair tacks
8.3.3.3.1 Rising sports injuries will drive growth in the meniscal repair tacks market
TABLE 129 MARKET FOR MENISCAL REPAIR TACKS, BY REGION, 2016–2019
TABLE 130 MARKET FOR MENISCAL REPAIR TACKS, BY REGION, 2020–2025
8.3.3.4 Meshes
8.3.3.4.1 Wear resistance, proper shaping, and holding capacity of bioresorbable implants increase the demand for bioresorbable meshes
TABLE 131 GLOBAL MARKET FOR MESHES, BY REGION, 2016–2019
TABLE 132 MARKET FOR MESHES, BY REGION, 2020–2025
8.3.4 SPINE
TABLE 133 MARKET FOR SPINE SURGERIES, BY TYPE, 2016–2019
TABLE 134 MARKET FOR SPINE SURGERIES, BY TYPE, 2020–2025
TABLE 135 MARKET FOR SPINE SURGERIES, BY REGION, 2016–2019
TABLE 136 MARKET FOR SPINE SURGERIES, BY REGION, 2020–2025
8.3.4.1 Spinal fusion
8.3.4.1.1 Introduction of minimally invasive spinal fusion procedures and better clinical outcomes to drive market growth
TABLE 137 GLOBAL MARKET FOR SPINAL FUSION SURGERIES, BY REGION, 2016–2019
TABLE 138 MARKET FOR SPINAL FUSION SURGERIES, BY REGION, 2020–2025
8.3.4.2 Minimally invasive fusion
8.3.4.2.1 Advantages such as lesser pain post surgery and faster recovery to drive the demand for minimally invasive fusion procedures
TABLE 139 MARKET FOR MINIMALLY INVASIVE FUSION SURGERIES, BY REGION, 2016–2019
TABLE 140 MARKET FOR MINIMALLY INVASIVE FUSION SURGERIES, BY REGION, 2020–2025
8.3.4.3 Motion preservation & dynamic stabilization
TABLE 141 MARKET FOR MOTION PRESERVATION & DYNAMIC STABILIZATION SURGERIES, BY PRODUCT, 2016–2019
TABLE 142 MARKET FOR MOTION PRESERVATION & DYNAMIC STABILIZATION SURGERIES, BY PRODUCT, 2020–2025
TABLE 143 BIOMATERIALS MARKET FOR MOTION PRESERVATION & DYNAMIC STABILIZATION SURGERIES, BY REGION, 2016–2019
TABLE 144 MARKET FOR MOTION PRESERVATION & DYNAMIC STABILIZATION SURGERIES, BY REGION, 2020–2025
8.3.4.3.1 Pedicle-based rod systems
8.3.4.3.1.1 Rising geriatric population will result in growth in the pedicle-based rod systems market
TABLE 145 MARKET FOR PEDICLE-BASED ROD SYSTEMS, BY REGION, 2016–2019
TABLE 146 MARKET FOR PEDICLE-BASED ROD SYSTEMS, BY REGION, 2020–2025
8.3.4.3.2 Interspinous spacers
8.3.4.3.2.1 High prevalence of degenerative spinal conditions will contribute to the growth of the interspinous spacers market
TABLE 147 MARKET FOR INTERSPINOUS SPACERS, BY REGION, 2016–2019
TABLE 148 MARKET FOR INTERSPINOUS SPACERS, BY REGION, 2020–2025
8.3.4.3.3 Artificial discs
8.3.4.3.3.1 High biocompatibility of biomaterials has led to their increased use in artificial discs
TABLE 149 GLOBAL MARKET FOR ARTIFICIAL DISCS, BY REGION, 2016–2019
TABLE 150 MARKET FOR ARTIFICIAL DISCS, BY REGION, 2020–2025
8.3.5 FRACTURE FIXATION DEVICES
TABLE 151 MARKET FOR FRACTURE FIXATION DEVICES, BY TYPE, 2016–2019
TABLE 152 MARKET FOR FRACTURE FIXATION DEVICES, BY TYPE, 2020–2025
TABLE 153 MARKET FOR FRACTURE FIXATION DEVICES, BY REGION, 2016–2019
TABLE 154 MARKET FOR FRACTURE FIXATION DEVICES, BY REGION, 2020–2025
8.3.5.1 Bone plates
8.3.5.1.1 Biomaterials form an integral component of bone plates due to their high biocompatibility
TABLE 155 GLOBAL MARKET FOR BONE PLATES, BY REGION, 2016–2019
TABLE 156 MARKET FOR BONE PLATES, BY REGION, 2020–2025
8.3.5.2 Screws
8.3.5.2.1 Screws made up of biomaterials such as stainless steel, titanium, and cobalt are extensively used in orthopedic procedures
TABLE 157 MARKET FOR SCREWS, BY REGION, 2016–2019
TABLE 158 MARKET FOR SCREWS, BY REGION, 2020–2025
8.3.5.3 Pins
8.3.5.3.1 Nonreactive metallic biomaterials such as stainless steel, titanium, and cobalt are majorly used to manufacture pins
TABLE 159 MARKET FOR PINS, BY REGION, 2016–2019
TABLE 160 MARKET FOR PINS, BY REGION, 2020–2025
8.3.5.4 Rods
8.3.5.4.1 Rods are preferred for fracture fixation procedures due to their high rigidity, easy mobility, and cost efficiency
TABLE 161 GLOBAL MARKET FOR RODS, BY REGION, 2016–2019
TABLE 162 MARKET FOR RODS, BY REGION, 2020–2025
8.3.5.5 Wires
8.3.5.5.1 Wires made up of metallic biomaterials are widely used to treat fractures of small bones
TABLE 163 MARKET FOR WIRES, BY REGION, 2016–2019
TABLE 164 MARKET FOR WIRES, BY REGION, 2020–2025
8.3.6 SYNTHETICS BONE GRAFTS
8.3.6.1 Growing geriatric population and increasing incidence of sports-related injuries are driving the market for synthetic bone grafts
TABLE 165 MARKET FOR SYNTHETIC BONE GRAFTS, BY REGION, 2016–2019
TABLE 166 MARKET FOR SYNTHETIC BONE GRAFTS, BY REGION, 2020–2025
8.4 OPHTHALMOLOGY
TABLE 167 GLOBAL MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2016–2019
TABLE 168 MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2020–2025
TABLE 169 MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY REGION, 2016–2019
TABLE 170 GLOBAL MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY REGION, 2020–2025
8.4.1 CONTACT LENSES
8.4.1.1 High cases of refractive errors and preference for contact lenses over spectacles to drive the market for contact lenses
TABLE 171 MARKET FOR CONTACT LENSES, BY REGION, 2016–2019
TABLE 172 MARKET FOR CONTACT LENSES, BY REGION, 2020–2025
8.4.2 INTRAOCULAR LENSES
8.4.2.1 Increasing prevalence of cataracts to drive the number of cataract surgeries performed
TABLE 173 BIOMATERIALS MARKET FOR INTRAOCULAR LENSES, BY REGION, 2016–2019
TABLE 174 MARKET FOR INTRAOCULAR LENSES, BY REGION, 2020–2025
8.4.3 FUNCTIONAL REPLACEMENT OF OCULAR TISSUES
8.4.3.1 Increasing funding and research activities for developing bionic eyes are driving the market for this application
TABLE 175 MARKET FOR FUNCTIONAL REPLACEMENT OF OCULAR TISSUES, BY REGION, 2016–2019
TABLE 176 GLOBAL MARKET FOR FUNCTIONAL REPLACEMENT OF OCULAR TISSUES, BY REGION, 2020–2025
8.4.4 SYNTHETIC CORNEAS
8.4.4.1 Growing number of corneal blindness cases worldwide to boost the demand for synthetic collagen biomaterials
TABLE 177 MARKET FOR SYNTHETIC CORNEAS, BY REGION, 2016–2019
TABLE 178 MARKET FOR SYNTHETIC CORNEAS, BY REGION, 2020–2025
8.4.5 OTHER OPHTHALMOLOGY APPLICATIONS
TABLE 179 GLOBAL MARKET FOR OTHER OPHTHALMOLOGY APPLICATIONS, BY REGION, 2016–2019
TABLE 180 MARKET FOR OTHER OPHTHALMOLOGY APPLICATIONS, BY REGION, 2020–2025
8.5 DENTAL
TABLE 181 MARKET FOR DENTAL APPLICATIONS, BY PRODUCT, 2016–2019
TABLE 182 GLOBAL MARKET FOR DENTAL APPLICATIONS, BY PRODUCT, 2020–2025
TABLE 183 MARKET FOR DENTAL APPLICATIONS, BY REGION, 2016–2019
TABLE 184 MARKET FOR DENTAL APPLICATIONS, BY REGION, 2020–2025
8.5.1 DENTAL IMPLANTS
8.5.1.1 Increasing awareness of dental services and improving quality of dental products are driving the growth of this market segment
TABLE 185 PERCENTAGE OF INDIVIDUALS WITH UNTREATED DENTAL CARIES IN THE US (2016)
TABLE 186 GLOBAL MARKET FOR DENTAL IMPLANTS, BY REGION, 2016–2019
TABLE 187 MARKET FOR DENTAL IMPLANTS, BY REGION, 2020–2025
8.5.2 DENTAL BONE GRAFTS & SUBSTITUTES
8.5.2.1 Growing demand for dental implants among people opting for cosmetic dentistry to drive market growth
TABLE 188 MARKET FOR DENTAL BONE GRAFTS & SUBSTITUTES, BY REGION, 2016–2019
TABLE 189 GLOBAL MARKET FOR DENTAL BONE GRAFTS & SUBSTITUTES, BY REGION, 2020–2025
8.5.3 DENTAL MEMBRANES
8.5.3.1 Dental membranes are widely used in oral and periodontal surgery to prevent unwanted infections in the oral cavity
TABLE 190 GLOBAL MARKET FOR DENTAL MEMBRANES, BY REGION, 2016–2019
TABLE 191 MARKET FOR DENTAL MEMBRANES, BY REGION, 2020–2025
8.5.4 TISSUE REGENERATION MATERIALS
8.5.4.1 Increasing prevalence of periodontal disease is driving the market for biomaterials in this particular application
TABLE 192 MARKET FOR TISSUE REGENERATION, BY REGION, 2016–2019
TABLE 193 GLOBAL MARKET FOR TISSUE REGENERATION, BY REGION, 2020–2025
8.6 PLASTIC SURGERY
TABLE 194 BIOMATERIALS MARKET FOR PLASTIC SURGERY, BY APPLICATION, 2016–2019
TABLE 195 MARKET FOR PLASTIC SURGERY, BY APPLICATION, 2020–2025
TABLE 196 MARKET FOR PLASTIC SURGERY, BY REGION, 2016–2019
TABLE 197 GLOBAL MARKET FOR PLASTIC SURGERY, BY REGION, 2020–2025
8.6.1 SOFT-TISSUE FILLERS
8.6.1.1 Advantages such as long-lasting capacity and less allergic reactions to drive the demand for soft-tissue fillers
TABLE 198 GLOBAL MARKET FOR SOFT-TISSUE FILLERS, BY REGION, 2016–2019
TABLE 199 MARKET FOR SOFT-TISSUE FILLERS, BY REGION, 2020–2025
8.6.2 CRANIOFACIAL SURGERY
8.6.2.1 Increasing incidence of trauma cases and head & neck cancer to increase the number of craniofacial surgeries
TABLE 200 MARKET FOR CRANIOFACIAL SURGERY, BY REGION, 2016–2019
TABLE 201 GLOBAL MARKET FOR CRANIOFACIAL SURGERY, BY REGION, 2020–2025
8.7 WOUND HEALING
TABLE 202 GLOBAL MARKET FOR WOUND HEALING APPLICATIONS, BY PRODUCT, 2016–2019
TABLE 203 MARKET FOR WOUND HEALING APPLICATIONS, BY PRODUCT, 2020–2025
TABLE 204 MARKET FOR WOUND HEALING APPLICATIONS, BY REGION, 2016–2019
TABLE 205 GLOBAL MARKET FOR WOUND HEALING APPLICATIONS, BY REGION, 2020–2025
8.7.1 WOUND CLOSURE DEVICES
TABLE 206 BIOMATERIALS MARKET FOR WOUND CLOSURE DEVICES, BY PRODUCT, 2016–2019
TABLE 207 MARKET FOR WOUND CLOSURE DEVICES, BY PRODUCT, 2020–2025
TABLE 208 MARKET FOR WOUND CLOSURE DEVICES, BY REGION, 2016–2019
TABLE 209 GLOBAL MARKET FOR WOUND CLOSURE DEVICES, BY REGION, 2020–2025
8.7.1.1 Sutures
8.7.1.1.1 Sutures can be used as advanced biologically active components enabling the delivery of drugs
TABLE 210 GLOBAL MARKET FOR SUTURES, BY REGION, 2016–2019
TABLE 211 MARKET FOR SUTURES, BY REGION, 2020–2025
8.7.1.2 Staples
8.7.1.2.1 Staples are easy to place and can shorten the closure by 70–80% compared to sutures
TABLE 212 MARKET FOR STAPLES, BY REGION, 2016–2019
TABLE 213 GLOBAL MARKET FOR STAPLES, BY REGION, 2020–2025
8.7.2 SURGICAL HEMOSTATS
8.7.2.1 Surgical hemostats have the ability to control bleeding and reduce the need for frequent blood transfusions during surgical procedures
TABLE 214 MARKET FOR SURGICAL HEMOSTATS, BY REGION, 2016–2019
TABLE 215 GLOBAL MARKET FOR SURGICAL HEMOSTATS, BY REGION, 2020–2025
8.7.3 INTERNAL TISSUE SEALANTS
8.7.3.1 Internal tissue sealants are made of biomaterials such as fibrin, gelatin, thrombin, synthetic polymers, and biosynthetic polymers
TABLE 216 MARKET FOR INTERNAL TISSUE SEALANTS, BY REGION, 2016–2019
TABLE 217 GLOBAL MARKET FOR INTERNAL TISSUE SEALANTS, BY REGION, 2020–2025
8.7.4 ADHESION BARRIERS
8.7.4.1 Biomaterials such as Teflon sheets, animal membranes, gold foil, silk, and rubber are used as adhesion barriers
TABLE 218 MARKET FOR ADHESION BARRIERS, BY REGION, 2016–2019
TABLE 219 BIOMATERIALS MARKET FOR ADHESION BARRIERS, BY REGION, 2020–2025
8.7.5 HERNIA MESHES
8.7.5.1 Meshes used in hernia repair are mainly made up of polymeric biomaterials
TABLE 220 GLOBAL MARKET FOR HERNIA MESHES, BY REGION, 2016–2019
TABLE 221 MARKET FOR HERNIA MESHES, BY REGION, 2020–2025
8.8 TISSUE ENGINEERING
TABLE 222 TISSUE ENGINEERING MARKET, BY APPLICATION, 2016–2019
TABLE 223 TISSUE ENGINEERING MARKET, BY APPLICATION, 2020–2025
TABLE 224 TISSUE ENGINEERING MARKET, BY REGION, 2016–2019
TABLE 225 TISSUE ENGINEERING MARKET, BY REGION, 2020–2025
8.8.1 SCAFFOLDS FOR REGENERATIVE MEDICINE
8.8.1.1 Rise in organ transplantation procedures to drive the market
TABLE 226 TISSUE ENGINEERING MARKET FOR SCAFFOLDS FOR REGENERATIVE MEDICINE, BY REGION, 2016–2019
TABLE 227 TISSUE ENGINEERING MARKET FOR SCAFFOLDS FOR REGENERATIVE MEDICINE, BY REGION, 2020–2025
8.8.2 NANOMATERIALS FOR BIOSENSING
8.8.2.1 Growth in this segment will be driven by rising research in the field of nanotechnology
TABLE 228 TISSUE ENGINEERING MARKET FOR NANOMATERIALS FOR BIOSENSING, BY REGION, 2016–2019
TABLE 229 TISSUE ENGINEERING MARKET FOR NANOMATERIALS FOR BIOSENSING, BY REGION, 2020–2025
8.8.3 TAILORING OF INORGANIC NANOPARTICLES
8.8.3.1 Growing demand for nanotechnological medical products will be a key factor in driving the growth of this market
TABLE 230 TISSUE ENGINEERING MARKET FOR TAILORING OF INORGANIC NANOPARTICLES, BY REGION, 2016–2019
TABLE 231 TISSUE ENGINEERING BIOMATERIALS MARKET FOR TAILORING OF INORGANIC NANOPARTICLES, BY REGION, 2020–2025
8.9 NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS
TABLE 232 BIOMATERIALS MARKET FOR NEUROLOGICAL/CNS APPLICATIONS, BY PRODUCT, 2016–2019
TABLE 233 MARKET FOR NEUROLOGICAL/CNS APPLICATIONS, BY PRODUCT, 2020–2025
TABLE 234 GLOBAL MARKET FOR NEUROLOGICAL/CNS APPLICATIONS, BY REGION, 2016–2019
TABLE 235 MARKET FOR NEUROLOGICAL/CNS APPLICATIONS, BY REGION, 2020–2025
8.9.1 SHUNTING SYSTEMS
8.9.1.1 Rising cases of hydrocephalus will boost the market growth
TABLE 236 GLOBAL MARKET FOR SHUNTING SYSTEMS, BY REGION, 2016–2019
TABLE 237 MARKET FOR SHUNTING SYSTEMS, BY REGION, 2020–2025
8.9.2 CORTICAL NEURAL PROSTHETICS
8.9.2.1 Polymer-coated CNPs are relatively new in the market and are mainly used to treat paralyzed patients
TABLE 238 GLOBAL MARKET FOR CORTICAL NEURAL PROSTHETICS, BY REGION, 2016–2019
TABLE 239 MARKET FOR CORTICAL NEURAL PROSTHETICS, BY REGION, 2020–2025
8.9.3 HYDROGEL SCAFFOLDS FOR CNS REPAIR
8.9.3.1 With increasing incidence of spinal cord surgeries, the demand for hydrogel scaffolds is expected to grow in the coming years
TABLE 240 GLOBAL MARKET FOR HYDROGEL SCAFFOLDS FOR CNS REPAIR, BY REGION, 2016–2019
TABLE 241 MARKET FOR HYDROGEL SCAFFOLDS FOR CNS REPAIR, BY REGION, 2020–2025
8.9.4 NEURAL STEM CELL ENCAPSULATION
8.9.4.1 Lack of substitutes for the treatment of neurotrauma is boosting the market growth
TABLE 242 BIOMATERIALS MARKET FOR NEURAL STEM CELL ENCAPSULATION, BY REGION, 2016–2019
TABLE 243 MARKET FOR NEURAL STEM CELL ENCAPSULATION, BY REGION, 2020–2025
8.10 OTHER APPLICATIONS
TABLE 244 OTHER BIOMATERIAL APPLICATIONS MARKET, BY TYPE, 2016–2019
TABLE 245 OTHER BIOMATERIAL APPLICATIONS MARKET, BY TYPE, 2020–2025
TABLE 246 OTHER BIOMATERIAL APPLICATIONS MARKET, BY REGION, 2016–2019
TABLE 247 OTHER BIOMATERIAL APPLICATIONS MARKET, BY REGION, 2020–2025
8.10.1 DRUG DELIVERY SYSTEMS
TABLE 248 GLOBAL MARKET FOR DRUG DELIVERY SYSTEMS, BY REGION, 2016–2019
TABLE 249 MARKET FOR DRUG DELIVERY SYSTEMS, BY REGION, 2020–2025
8.10.2 GASTROINTESTINAL APPLICATIONS
TABLE 250 GLOBAL MARKET FOR GASTROINTESTINAL APPLICATIONS, BY REGION, 2016–2019
TABLE 251 MARKET FOR GASTROINTESTINAL APPLICATIONS, BY REGION, 2020–2025
8.10.3 BARIATRIC SURGERY
TABLE 252 GLOBAL MARKET FOR BARIATRIC SURGERY, BY REGION, 2016–2019
TABLE 253 MARKET FOR BARIATRIC SURGERY, BY REGION, 2020–2025
8.10.4 URINARY APPLICATIONS
TABLE 254 GLOBAL MARKET FOR URINARY APPLICATIONS, BY REGION, 2016–2019
TABLE 255 MARKET FOR URINARY APPLICATIONS, BY REGION, 2020–2025
9 BIOMATERIALS MARKET, BY REGION (Page No. - 204)
9.1 INTRODUCTION
TABLE 256 BIOMATERIALS MARKET, BY REGION, 2016–2019
TABLE 257 MARKET, BY REGION, 2020–2025
FIGURE 33 MARKET, BY REGION, 2020 VS. 2025
9.2 NORTH AMERICA
FIGURE 34 NORTH AMERICA: BIOMATERIALS MARKET SNAPSHOT
TABLE 258 NORTH AMERICA: MARKET, BY COUNTRY, 2016–2019
TABLE 259 NORTH AMERICA: MARKET, BY COUNTRY, 2020–2025
TABLE 260 NORTH AMERICA: MARKET, BY TYPE, 2016–2019
TABLE 261 NORTH AMERICA: MARKET, BY TYPE, 2020–2025
TABLE 262 NORTH AMERICA: MARKET, BY APPLICATION, 2016–2019
TABLE 263 NORTH AMERICA: MARKET, BY APPLICATION, 2020–2025
9.2.1 US
9.2.1.1 US dominates the North American biomaterials market
TABLE 264 US: BIOMATERIALS MARKET, BY TYPE, 2016–2019
TABLE 265 US: MARKET, BY TYPE, 2020–2025
TABLE 266 US: MARKET, BY APPLICATION, 2016–2019
TABLE 267 US: MARKET, BY APPLICATION, 2020–2025
9.2.2 CANADA
9.2.2.1 Increasing incidence of cardiovascular diseases to drive market growth in Canada
TABLE 268 CANADA: BIOMATERIALS MARKET, BY TYPE, 2016–2019
TABLE 269 CANADA: MARKET, BY TYPE, 2020–2025
TABLE 270 CANADA: MARKET, BY APPLICATION, 2016–2019
TABLE 271 CANADA: MARKET, BY APPLICATION, 2020–2025
9.3 EUROPE
TABLE 272 EUROPE: BIOMATERIALS MARKET, BY COUNTRY, 2016–2019
TABLE 273 EUROPE: MARKET, BY COUNTRY, 2020–2025
TABLE 274 EUROPE: MARKET, BY TYPE, 2016–2019
TABLE 275 EUROPE: MARKET, BY TYPE, 2020–2025
TABLE 276 EUROPE: MARKET, BY APPLICATION, 2016–2019
TABLE 277 EUROPE: MARKET, BY APPLICATION, 2020–2025
9.3.1 GERMANY
9.3.1.1 Large medical device market to support the adoption of biomaterials in Germany
TABLE 278 GERMANY: BIOMATERIALS MARKET, BY TYPE, 2016–2019
TABLE 279 GERMANY: MARKET, BY TYPE, 2020–2025
TABLE 280 GERMANY: MARKET, BY APPLICATION, 2016–2019
TABLE 281 GERMANY: MARKET, BY APPLICATION, 2020–2025
9.3.2 UK
9.3.2.1 Availability of funds and the increasing number of cardiovascular procedures to drive the biomaterials market in the UK
TABLE 282 UK: BIOMATERIALS MARKET, BY TYPE, 2016–2019
TABLE 283 UK: MARKET, BY TYPE, 2020–2025
TABLE 284 UK: MARKET, BY APPLICATION, 2016–2019
TABLE 285 UK: MARKET, BY APPLICATION, 2020–2025
9.3.3 FRANCE
9.3.3.1 Rising aging population and associated diseases to drive the market in France
TABLE 286 FRANCE: BIOMATERIALS MARKET, BY TYPE, 2016–2019
TABLE 287 FRANCE: MARKET, BY TYPE, 2020–2025
TABLE 288 FRANCE: MARKET, BY APPLICATION, 2016–2019
TABLE 289 FRANCE: MARKET, BY APPLICATION, 2020–2025
9.3.4 SPAIN
9.3.4.1 Increasing research activities on biomaterials to drive growth in Spain
TABLE 290 SPAIN: BIOMATERIALS MARKET, BY TYPE, 2016–2019
TABLE 291 SPAIN: MARKET, BY TYPE, 2020–2025
TABLE 292 SPAIN: MARKET, BY APPLICATION, 2016–2019
TABLE 293 SPAIN: MARKET, BY APPLICATION, 2020–2025
9.3.5 REST OF EUROPE (ROE)
TABLE 294 ROE: BIOMATERIALS MARKET, BY TYPE, 2016–2019
TABLE 295 ROE: MARKET, BY TYPE, 2020–2025
TABLE 296 ROE: MARKET, BY APPLICATION, 2016–2019
TABLE 297 ROE: MARKET, BY APPLICATION, 2020–2025
9.4 ASIA PACIFIC
FIGURE 35 ASIA PACIFIC: BIOMATERIALS MARKET SNAPSHOT
TABLE 298 APAC: MARKET, BY COUNTRY, 2016–2019
TABLE 299 APAC: MARKET, BY COUNTRY, 2020–2025
TABLE 300 APAC: MARKET, BY TYPE, 2016–2019
TABLE 301 APAC: MARKET, BY TYPE, 2020–2025
TABLE 302 APAC: MARKET, BY APPLICATION, 2016–2019
TABLE 303 APAC: MARKET, BY APPLICATION, 2020–2025
9.4.1 JAPAN
9.4.1.1 Growing medical devices industry to drive biomaterials market growth
TABLE 304 JAPAN: BIOMATERIALS MARKET, BY TYPE, 2016–2019
TABLE 305 JAPAN: MARKET, BY TYPE, 2020–2025
TABLE 306 JAPAN: MARKET, BY APPLICATION, 2016–2019
TABLE 307 JAPAN: MARKET, BY APPLICATION, 2020–2025
9.4.2 CHINA
9.4.2.1 Lucrative medical devices industry in China to drive market growth
TABLE 308 CHINA: BIOMATERIALS MARKET, BY TYPE, 2016–2019
TABLE 309 CHINA: MARKET, BY TYPE, 2020–2025
TABLE 310 CHINA: MARKET, BY APPLICATION, 2016–2019
TABLE 311 CHINA: MARKET, BY APPLICATION, 2020–2025
9.4.3 INDIA
9.4.3.1 Large population base and growing medical tourism in India to drive the growth of the biomaterials market
TABLE 312 INDIA: BIOMATERIALS MARKET, BY TYPE, 2016–2019
TABLE 313 INDIA: MARKET, BY TYPE, 2020–2025
TABLE 314 INDIA: MARKET, BY APPLICATION, 2016–2019
TABLE 315 INDIA: MARKET, BY APPLICATION, 2020–2025
9.4.4 REST OF ASIA PACIFIC (ROAPAC)
TABLE 316 ROAPAC: BIOMATERIALS MARKET, BY TYPE, 2016–2019
TABLE 317 ROAPAC: MARKET, BY TYPE, 2020–2025
TABLE 318 ROAPAC: MARKET, BY APPLICATION, 2016–2019
TABLE 319 ROAPAC: MARKET, BY APPLICATION, 2020–2025
9.5 REST OF THE WORLD (ROW)
TABLE 320 ROW: BIOMATERIALS MARKET, BY TYPE, 2016–2019
TABLE 321 ROW: MARKET, BY TYPE, 2020–2025
TABLE 322 ROW: MARKET, BY APPLICATION, 2016–2019
TABLE 323 ROW: MARKET, BY APPLICATION, 2020–2025
10 COMPETITIVE LANDSCAPE (Page No. - 240)
10.1 OVERVIEW
10.2 MARKET RANKING ANALYSIS
FIGURE 36 COMPANY RANKING IN THE BIOMATERIALS MARKET, 2019
10.3 MARKET EVALUATION FRAMEWORK
TABLE 324 MARKET EVALUATION FRAMEWORK: PRODUCT LAUNCHES & EXPANSIONS—THE MAJOR STRATEGIES ADOPTED BY PLAYERS
10.4 COMPETITIVE SCENARIO
10.4.1 KEY PRODUCT LAUNCHES
10.4.2 KEY COLLABORATIONS, PARTNERSHIPS, AND AGREEMENTS
10.4.3 KEY ACQUISITIONS
10.4.4 KEY EXPANSIONS
11 COMPANY EVALUATION MATRIX AND COMPANY PROFILES (Page No. - 244)
11.1 OVERVIEW
11.2 GLOBAL BIOMATERIALS MARKET: COMPANY EVALUATION MATRIX
11.2.1 STARS
11.2.2 EMERGING LEADERS
11.2.3 PERVASIVE PLAYERS
11.2.4 PARTICIPANTS
FIGURE 37 GLOBAL MARKET: COMPANY EVALUATION MATRIX, 2019
11.3 COMPANY PROFILES
(Business overview, Products offered, Recent developments & MnM View)*
11.3.1 BASF SE
FIGURE 38 BASF: COMPANY SNAPSHOT
11.3.2 COVESTRO AG
FIGURE 39 COVESTRO: COMPANY SNAPSHOT
11.3.3 CELANESE CORPORATION
FIGURE 40 CELANESE CORPORATION: COMPANY SNAPSHOT
11.3.4 CARPENTER TECHNOLOGY CORPORATION
FIGURE 41 CARPENTER TECHNOLOGY CORPORATION: COMPANY SNAPSHOT
11.3.5 ROYAL DSM
FIGURE 42 ROYAL DSM: COMPANY SNAPSHOT
11.3.6 CORBION
FIGURE 43 CORBION: COMPANY SNAPSHOT
11.3.7 EVONIK INDUSTRIES
FIGURE 44 EVONIK INDUSTRIES: COMPANY SNAPSHOT
11.3.8 VICTREX PLC
FIGURE 45 VICTREX PLC: COMPANY SNAPSHOT
11.3.9 CERAMTEC GMBH
FIGURE 46 CERAMTEC GMBH: COMPANY SNAPSHOT
11.3.10 MITSUBISHI CHEMICAL HOLDINGS CORPORATION (ADVANSOURCE BIOMATERIALS CORP.)
FIGURE 47 MITSUBISHI CHEMICAL HOLDINGS CORPORATION: COMPANY SNAPSHOT
11.3.11 COORSTEK INC.
11.3.12 BERKELEY ADVANCED BIOMATERIALS
11.3.13 CAM BIOCERAMICS B.V.
11.3.14 ZEUS INDUSTRIAL PRODUCTS, INC.
11.3.15 GELITA AG
11.3.16 RDI GROUP (COLLAGEN SOLUTIONS PLC)
11.3.17 RITON BIOMATERIAL CO., LTD.
11.3.18 ARTOSS, INC.
11.3.19 NOBEL BIOMATERIALS
11.3.20 DIMENSION INX
*Details on Business overview, Products offered, Recent developments & MnM View might not be captured in case of unlisted companies.
12 ADJACENT/RELATED MARKETS (Page No. - 277)
12.1 INTRODUCTION
12.2 LIMITATIONS
12.3 MEDICAL CERAMICS MARKET
12.3.1 MARKET DEFINITION
12.3.2 MARKET OVERVIEW
12.3.3 MEDICAL CERAMICS MARKET, BY REGION
TABLE 325 MEDICAL CERAMICS MARKET, BY REGION, 2018–2025
12.3.3.1 North America
TABLE 326 NORTH AMERICA: MEDICAL CERAMICS MARKET, BY COUNTRY, 2018–2025
12.3.3.2 Europe
TABLE 327 EUROPE: MEDICAL CERAMICS MARKET, BY COUNTRY, 2018–2025
12.3.3.3 Asia Pacific
TABLE 328 ASIA PACIFIC: MEDICAL CERAMICS MARKET, BY COUNTRY, 2018–2025
12.3.3.4 Latin America
TABLE 329 LATIN AMERICA: MEDICAL CERAMICS MARKET, BY COUNTRY, 2018–2025
12.4 BONE CEMENT & GLUE MARKET
12.4.1 MARKET DEFINITION
12.4.2 MARKET OVERVIEW
12.4.3 BONE CEMENT & GLUE MARKET, BY REGION
TABLE 330 BONE CEMENT & GLUE MARKET, BY REGION, 2015–2022
12.4.3.1 North America
TABLE 331 NORTH AMERICA: BONE CEMENT & GLUE MARKET, BY COUNTRY, 2015–2022
12.4.3.2 Europe
TABLE 332 EUROPE: BONE CEMENT & GLUE MARKET, BY COUNTRY, 2015–2022
12.4.3.3 Asia Pacific
TABLE 333 ASIA PACIFIC: BONE CEMENT & GLUE MARKET, BY COUNTRY, 2015–2022
13 APPENDIX (Page No. - 283)
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
This study involved four major activities in estimating the current size of the biomaterials market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.
Secondary Research
Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the biomaterials market. The secondary sources used for this study include Some of the key secondary sources referred to for this study include Centre for Advanced Materials and Biomaterials Research (CAMBR), Institute of Biomaterial Science, Medical Design Technology Magazine, Centre for Biomedical and Biomaterials Research (CBBR), Institute of Biomaterials, Biomedical Engineering, and Biomaterials Research Center. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects of the market. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the biomaterials market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry and market have been identified through extensive secondary research
- The revenues generated from the biomaterials business of leading players have been determined through primary and secondary research
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources
Data Triangulation
After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Report Objectives
- To define, describe, and forecast the global biomaterials market based on the type, application and region
- To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, challenges, opportunities and trends)
- To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall biomaterials market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, Asia Pacific, and Rest of the World
- To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- To track and analyze competitive developments such as acquisitions, product launches, expansions, agreements, partnerships, and R&D activities in the biomaterials market.
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:
Company Information
- An additional five company profiles
Growth opportunities and latent adjacency in Biomaterials Market
What are the recent developments in the Global Biomaterials Market?
Which factors are being the game changer in the global growth of Biomaterials Market?
Which of the geographical segment holds the major share of the Biomaterials Market?